celecoxib has been researched along with Spinal Muscular Atrophies of Childhood in 1 studies
Spinal Muscular Atrophies of Childhood: A group of recessive inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I (Werdnig-Hoffman disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. (J Med Genet 1996 Apr:33(4):281-3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farooq, F | 1 |
| AbadÃa-Molina, F | 1 |
| MacKenzie, D | 1 |
| Hadwen, J | 1 |
| Shamim, F | 1 |
| O'Reilly, S | 1 |
| Holcik, M | 1 |
| MacKenzie, A | 1 |
1 other study available for celecoxib and Spinal Muscular Atrophies of Childhood
| Article | Year |
|---|---|
Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation.
Topics: Adolescent; Animals; Brain; Celecoxib; Cells, Cultured; Child; Child, Preschool; Disease Models, Ani | 2013 |